Results 41 to 50 of about 369,028 (215)

The diagnostic and prognostic value of tissue Doppler imaging during dobutamine stress echocardiography in end-stage renal disease

open access: yes, 2009
Objective: To determine whether a quantitative measurement of peak systolic velocity (PSV) during dobutamine stress echocardiography (DSE) detects severe coronary artery disease (CAD) and predicts mortality in patients with end-stage renal disease ...
Pellerin, D.   +7 more
core   +1 more source

Autosomal dominant polycystic kidney disease in hemodialysis patients in southern Brazil [PDF]

open access: yes, 2014
INTRODUCTION: Autosomal dominant polycystic kidney disease is the most common hereditary renal disease in humans. OBJECTIVE: To examine the prevalence, clinical and laboratory characteristics of patients with polycystic kidneys and relate disease ...
Torres, Paulo Roberto Aranha   +17 more
core   +1 more source

Oral Anticoagulant Initiation in Patients With Kidney Failure on Hemodialysis Newly Diagnosed With Atrial Fibrillation (2007-2020): An Observational Study of Trends and Disparities

open access: yesKidney Medicine
Rationale & Objective: Atrial fibrillation (AF) is common in patients with kidney failure on hemodialysis (HD), but few patients receive oral anticoagulant (OAC) treatment.
Wolfgang C. Winkelmayer   +6 more
doaj   +1 more source

Dynamic left ventricular obstruction: A potential cause of angina in end stage renal disease

open access: yes, 2006
Background Patients with end stage renal disease (ESRD) often have angina which cannot be explained by coronary artery disease (CAD) alone. Symptoms are often attributed to systolic and diastolic dysfunction, arrhythmia or microvascular disease.
Pellerin, D.   +5 more
core   +1 more source

Role of excretory graft function for erythropoietin formation after renal transplantation

open access: yes, 1990
To examine the role of renal excretory function for erythropoietin (EPO) formation we have determined the kinetics of plasma immunoreactive EPO (irEPO) in patients with end-stage renal disease undergoing renal allotransplantation (RTX).
V. KLIEM   +13 more
core   +1 more source

Bardet-Biedl Syndrome with End Stage Renal Disease

open access: yesIranian Journal of Medical Sciences, 2016
Bardet-Biedl syndrome (BBS) is one of the rare autosomal recessive disorders that affect multiple organs of the body. The signs and symptoms of this condition vary among affected individuals, even among members of the same family.
Rajendrakumar Parakh   +1 more
doaj  

Incidence and mortality rates of varicella among end stage renal disease (ESRD) patients in Singapore General Hospital, a 12-year review

open access: yesBMC Infectious Diseases, 2018
Background End stage renal disease (ESRD)/ end stage renal failure (ESRF) is on the rise globally and especially in Singapore. Varicella or chickenpox is not uncommon among adults especially ESRD/ESRF patients. It has been reported to cause complications
Chong Yau Ong   +5 more
doaj   +1 more source

Risk factors for nasal carriage of methicillin-resistant Staphylococcus aureus among patients with end-stage renal disease in Taiwan

open access: yes, 2014
Background/Purpose: Patients with end-stage renal disease (ESRD) are at particular risk for methicillin-resistant Staphylococcus aureus (MRSA) infections, especially via nasal colonization of MRSA.
林裕? ;陳永銘 ;薛博仁 ;吳允升 ;吳寬墩 ;林彥宏   +1 more
core   +1 more source

End-stage Renal Disease and Economic Incentives: The International Study of Health Care Organization and Financing [PDF]

open access: yes
End-stage renal disease (ESRD), or kidney failure, is a debilitating, costly, and increasingly common medical condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care.
Margaret A. Eichleay   +3 more
core  

Comparison of Anti-Xa Activity after a Single Intravenous Bolus of Low- Dose Enoxaparin in Patients with and without End-Stage Renal Disease

open access: yes, 2011
This study was designed to evaluate anti-Xa activity hourly during the first 3 h after a single intravenous bolus of 0.5 mg/kg enoxaparin in 30 patients with end-stage renal disease (ESRD) who underwent haemodialysis, and in 30 patients with normal or ...
王偉傑;林韋丞;吳學明;趙嘉倫   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy